SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The March 2024 quarter revenue stood at Rs. 924.03 millions, up 11.92% as compared to Rs. 825.60 millions during the corresponding quarter last year.A radical decline of -82.07% was reported in the net profit of the company for the quarter ended March 2024 to Rs. 31.38  millions from Rs. 174.97 millions.The company reported a good operating profit of 324.54 millions compared to 260.92 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 924.03 825.60 11.92 3654.69 3115.29 17.31 3654.69 3115.29 17.31
Other Income 32.10 28.10 14.23 588.09 98.08 499.60 588.09 98.08 499.60
PBIDT 324.54 260.92 24.38 1639.95 846.96 93.63 1639.95 846.96 93.63
Interest 0.48 0.57 -15.79 1.57 1.35 16.30 1.57 1.35 16.30
PBDT 134.58 260.35 -48.31 1448.90 845.61 71.34 1448.90 845.61 71.34
Depreciation 30.67 27.57 11.24 108.98 102.83 5.98 108.98 102.83 5.98
PBT 103.91 232.78 -55.36 1339.92 742.78 80.39 1339.92 742.78 80.39
TAX 72.53 57.81 25.46 258.69 187.51 37.96 258.69 187.51 37.96
Deferred Tax -2.83 5.52 -151.27 -10.82 4.97 -317.71 -10.82 4.97 -317.71
PAT 31.38 174.97 -82.07 1081.23 555.27 94.72 1081.23 555.27 94.72
Equity 223.65 223.65 0.00 223.65 223.65 0.00 223.65 223.65 0.00
PBIDTM(%) 35.12 31.60 11.13 44.87 27.19 65.05 44.87 27.19 65.05

Advanced Enzyme Share Price

300.20 1.20 (0.40%)
21-Apr-2026 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1220.90
Cipla 1231.15
Zydus Lifesciences 927.40
Lupin 2324.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×